|
1
|
Kent KC: Clinical practice. Abdominal
aortic aneurysms. N Engl J Med. 371:2101–2108. 2014.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Dereziński TL, Fórmankiewicz B, Migdalski
A, Brazis P, Jakubowski G, Woda Ł and Jawień A: The prevalence of
abdominal aortic aneurysms in the rural/urban population in central
Poland-Gniewkowo aortic study. Kardiol Pol. 75:705–710.
2017.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Stuntz M: Modeling the burden of abdominal
aortic aneurysm in the USA in 2013. Cardiology. 135:127–131.
2016.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Kühnl A, Erk A, Trenner M, Salvermoser M,
Schmid V and Eckstein HH: Incidence, treatment and mortality in
patients with abdominal aortic aneurysms. Dtsch Arztebl Int.
114:391–398. 2017.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Lederle FA, Kyriakides TC, Stroupe KT,
Freischlag JA, Padberg FT Jr, Matsumura JS, Huo Z and Johnson GR:
OVER Veterans Affairs Cooperative Study Group. Open versus
endovascular repair of abdominal aortic aneurysm. N Engl J Med.
380:2126–2135. 2019.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Thompson RW, Liao S and Curci JA: Vascular
smooth muscle cell apoptosis in abdominal aortic aneurysms. Coron
Artery Dis. 8:623–631. 1997.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Liang B, Che J, Zhao H, Zhang Z and Shi G:
MiR-195 promotes abdominal aortic aneurysm media remodeling by
targeting Smad3. Cardiovasc Ther. 35(e12286)2017.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Zhao F, Chen T and Jiang N:
CDR1as/miR-7/CKAP4 axis contributes to the pathogenesis of
abdominal aortic aneurysm by regulating the proliferation and
apoptosis of primary vascular smooth muscle cells. Exp Ther Med.
19:3760–3766. 2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Cao X, Cai Z, Liu J, Zhao Y, Wang X, Li X
and Xia H: miRNA-504 inhibits p53-dependent vascular smooth muscle
cell apoptosis and may prevent aneurysm formation. Mol Med Rep.
16:2570–2578. 2017.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Zhang Y, Liu Z, Zhou M and Liu C:
MicroRNA-129-5p inhibits vascular smooth muscle cell proliferation
by targeting Wnt5a. Exp Ther Med. 12:2651–2656. 2016.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Zhao L, Ouyang Y, Bai Y, Gong J and Liao
H: miR-155-5p inhibits the viability of vascular smooth muscle cell
via targeting FOS and ZIC3 to promote aneurysm formation. Eur J
Pharmacol. 853:145–152. 2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Yue J, Zhu T, Yang J, Si Y, Xu X, Fang Y
and Fu W: CircCBFB-mediated miR-28-5p facilitates abdominal aortic
aneurysm via LYPD3 and GRIA4. Life Sci. 253(117533)2020.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Maegdefessel L, Azuma J, Toh R, Deng A,
Merk DR, Raiesdana A, Leeper NJ, Raaz U, Schoelmerich AM, McConnell
MV, et al: MicroRNA-21 blocks abdominal aortic aneurysm development
and nicotine-augmented expansion. Sci Transl Med.
4(122ra22)2012.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Peng J, He X, Zhang L and Liu P:
MicroRNA-26a protects vascular smooth muscle cells against
H2O2-induced injury through activation of the PTEN/AKT/mTOR
pathway. Int J Mol Med. 42:1367–1378. 2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Shen G, Sun Q, Yao Y, Li S, Liu G, Yuan C,
Li H, Xu Y and Wang H: Role of ADAM9 and miR-126 in the development
of abdominal aortic aneurysm. Atherosclerosis. 297:47–54.
2020.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Gan S, Pan Y and Mao J: miR-30a-GNG2 and
miR-15b-ACSS2 interaction pairs may be potentially crucial for
development of abdominal aortic aneurysm by influencing
inflammation. DNA Cell Biol. 38:1540–1556. 2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Agarwal V, Bell GW, Nam JW and Bartel DP:
Predicting effective microRNA target sites in mammalian mRNAs.
Elife. 4(e05005)2015.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Zhang Z, Zou G, Chen X, Lu W, Liu J, Zhai
S and Qiao G: Knockdown of lncRNA PVT1 inhibits vascular smooth
muscle cell apoptosis and extracellular matrix disruption in a
murine abdominal aortic aneurysm model. Mol Cells. 42:218–227.
2019.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Xue M, Li G, Li D, Wang Z, Mi L, Da J and
Jin X: Up-regulated MCPIP1 in abdominal aortic aneurysm is
associated with vascular smooth muscle cell apoptosis and MMPs
production. Biosci Rep. 39(BSR20191252)2019.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Dong Y, Zhang N, Zhao S, Chen X, Li F and
Tao X: miR-221-3p and miR-15b-5p promote cell proliferation and
invasion by targeting Axin2 in liver cancer. Oncol Lett.
18:6491–6500. 2019.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Zhao C, Li Y, Chen G, Wang F, Shen Z and
Zhou R: Overexpression of miR-15b-5p promotes gastric cancer
metastasis by regulating PAQR3. Oncol Rep. 38:352–358.
2017.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Wu B, Liu G, Jin Y, Yang T, Zhang D, Ding
L, Zhou F, Pan Y and Wei Y: miR-15b-5p promotes growth and
metastasis in breast cancer by targeting HPSE2. Front Oncol.
10(108)2020.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Sun Y, Gao Y, Song T, Yu C, Nie Z and Wang
X: MicroRNA-15b participates in the development of peripheral
arterial disease by modulating the growth of vascular smooth muscle
cells. Exp Ther Med. 18:77–84. 2019.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Chen R, Sheng L, Zhang HJ, Ji M and Qian
WQ: miR-15b-5p facilitates the tumorigenicity by targeting RECK and
predicts tumour recurrence in prostate cancer. J Cell Mol Med.
22:1855–1863. 2018.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Hur H, Kim YB, Ham IH and Lee D: Loss of
ACSS2 expression predicts poor prognosis in patients with gastric
cancer. J Surg Oncol. 112:585–591. 2015.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Bae JM, Kim JH, Oh HJ, Park HE, Lee TH,
Cho NY and Kang GH: Downregulation of acetyl-CoA synthetase 2 is a
metabolic hallmark of tumor progression and aggressiveness in
colorectal carcinoma. Mod Pathol. 30:267–277. 2017.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Sun L, Kong Y, Cao M, Zhou H, Li H, Cui Y,
Fang F, Zhang W, Li J, Zhu X, et al: Decreased expression of
acetyl-CoA synthase 2 promotes metastasis and predicts poor
prognosis in hepatocellular carcinoma. Cancer Sci. 108:1338–1346.
2017.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Yao L, Guo X and Gui Y: Acetyl-CoA
synthetase 2 promotes cell migration and invasion of renal cell
carcinoma by upregulating lysosomal-associated membrane protein 1
expression. Cell Physiol Biochem. 45:984–992. 2018.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Zhang S, He J, Jia Z, Yan Z and Yang J:
Acetyl-CoA synthetase 2 enhances tumorigenesis and is indicative of
a poor prognosis for patients with renal cell carcinoma. Urol
Oncol. 36:243.e9–243.e20. 2018.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Mi L, Zhou Y, Wu D, Tao Q, Wang X, Zhu H,
Gao X, Wang J, Ling R, Deng J, et al: ACSS2/AMPK/PCNA
pathway-driven proliferation and chemoresistance of esophageal
squamous carcinoma cells under nutrient stress. Mol Med Rep.
20:5286–5296. 2019.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Huang Z, Zhang M, Plec AA, Estill SJ, Cai
L, Repa JJ, McKnight SL and Tu BP: ACSS2 promotes systemic fat
storage and utilization through selective regulation of genes
involved in lipid metabolism. Proc Natl Acad Sci USA.
115:E9499–E9506. 2018.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Lee MY, Yeon A, Shahid M, Cho E, Sairam V,
Figlin R, Kim KH and Kim J: Reprogrammed lipid metabolism in
bladder cancer with cisplatin resistance. Oncotarget.
9:13231–13243. 2018.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Xu H, Luo J, Ma G, Zhang X, Yao D, Li M
and Loor JJ: Acyl-CoA synthetase short-chain family member 2
(ACSS2) is regulated by SREBP-1 and plays a role in fatty acid
synthesis in caprine mammary epithelial cells. J Cell Physiol.
233:1005–1016. 2018.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Chapple KS, Parry DJ, McKenzie S,
MacLennan KA, Jones P and Scott DJ: Cyclooxygenase-2 expression and
its association with increased angiogenesis in human abdominal
aortic aneurysms. Ann Vasc Surg. 21:61–66. 2007.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Ghoshal S and Loftin CD: Cyclooxygenase-2
inhibition attenuates abdominal aortic aneurysm progression in
hyperlipidemic mice. PLoS One. 7(e44369)2012.PubMed/NCBI View Article : Google Scholar
|
|
37
|
King VL, Trivedi DB, Gitlin JM and Loftin
CD: Selective cyclooxygenase-2 inhibition with celecoxib decreases
angiotensin II-induced abdominal aortic aneurysm formation in mice.
Arterioscler Thromb Vasc Biol. 26:1137–1143. 2006.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Mukherjee K, Gitlin JM and Loftin CD:
Effectiveness of cyclooxygenase-2 inhibition in limiting abdominal
aortic aneurysm progression in mice correlates with a
differentiated smooth muscle cell phenotype. J Cardiovasc
Pharmacol. 60:520–529. 2012.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Gitlin JM, Trivedi DB, Langenbach R and
Loftin CD: Genetic deficiency of cyclooxygenase-2 attenuates
abdominal aortic aneurysm formation in mice. Cardiovasc Res.
73:227–236. 2007.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Walton LJ, Franklin IJ, Bayston T, Brown
LC, Greenhalgh RM, Taylor GW and Powell JT: Inhibition of
prostaglandin E2 synthesis in abdominal aortic aneurysms:
Implications for smooth muscle cell viability, inflammatory
processes, and the expansion of abdominal aortic aneurysms.
Circulation. 100:48–54. 1999.PubMed/NCBI View Article : Google Scholar
|
